ABBOTT LABORATORIES Net Cash Provided by (Used in) Continuing Operations
ABBOTT LABORATORIES (ABT) reported Net Cash Provided by (Used in) Continuing Operations of $3.99 billion for the 12-month period ending 2012-12-31, per its 10-K filed 2013-02-15.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NetCashProvidedByUsedInContinuingOperations · last filed 2013-02-15
- ABBOTT LABORATORIES net cash provided by (used in) continuing operations for fiscal 2012 was $3.99B, a 26.07% increase from fiscal 2011.
- ABBOTT LABORATORIES net cash provided by (used in) continuing operations for fiscal 2011 was $3.16B.
- ABBOTT LABORATORIES net cash provided by (used in) continuing operations for fiscal 2010 was -$5.16B.
| Period end | Net Cash Provided by (Used in) Continuing Operations 12 month |
|---|---|
| 2012-12-31 | $3.99B 10-K · filed 2013-02-15 |
| 2011-12-31 | $3.16B 10-K · filed 2013-02-15 |
| 2010-12-31 | -$5.16B 10-K · filed 2013-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |